drugset / Trial / NCT04883775
Study of a New Technique for Imaging Pancreatic Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to see how well the experimental imaging agent 89Zr-DFO-HuMab-5B1 attaches to pancreatic tumors, and to find out whether PET/CT scans done with this imaging agent produce better images of cancer.
Timeline
- Start
- 2021-05-10
- Primary completion
- 2025-01-27
- Completion
- 2025-01-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MVT-2163 | Diagnostic / imaging agent | 3 mg | Intravenous |
| Subject | MVT-5873 | Monoclonal antibody | — | Intravenous |